| Merck (Schweiz) AG - Erbitux 100 mg/20 ml, Infusionslösung |
| 56072 | | 02 | | Erbitux 100 mg/20 ml | | Infusionslösung | | L01FE01 | | Cetuximab | | 01.10.2007 | | |
|
| Composition |
| cetuximabum 100 mg, natrii chloridum, glycinum, polysorbatum 80, acidum citricum monohydricum, natrii hydroxidi solutio 1 mol/L, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 58 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | | | Active Agent | Dose |
|---|
| Cetuximab | 100mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Cetuximab | 100 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Glycin | | | Mol/l | | | Sodium Chloride | | | Natrii Hydroxidi Solutio | 1 | | Polysorbatum 80 | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 20 ml | 187.45 | 220.30 | A | SL | No |
|
